MacroGenics, Inc.
MGNX
$1.39
$0.1310.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -82.52% | 925.36% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -82.52% | 925.36% | |||
| Cost of Revenue | 4.64% | 596.78% | |||
| Gross Profit | -136.65% | 1,350.00% | |||
| SG&A Expenses | 97.18% | -2.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.73% | -18.07% | |||
| Operating Income | -197.50% | 193.14% | |||
| Income Before Tax | -125.71% | 201.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -127.39% | 201.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -127.39% | 201.16% | |||
| EBIT | -197.50% | 193.14% | |||
| EBITDA | -190.64% | 199.39% | |||
| EPS Basic | -127.37% | 201.02% | |||
| Normalized Basic EPS | -190.03% | 201.03% | |||
| EPS Diluted | -127.79% | 200.83% | |||
| Normalized Diluted EPS | -190.21% | 200.83% | |||
| Average Basic Shares Outstanding | 0.06% | 0.13% | |||
| Average Diluted Shares Outstanding | -0.13% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||